Lamotrigine hypersensitivity in childhood epilepsy

Paola Iannetti, Umberto Raucci, Piergiorgio Zuccaro, Roberta Pacifici

Research output: Contribution to journalArticlepeer-review


Purpose: To evaluate the effect of lamotrigine (LTG) on several humoral and cellular immune functions in children with epilepsy and the change in immunological status in patient with LTG-induced rash. Methods: Sixteen children with epilepsy of unknown origin or secondary to various etiologies undergoing treatment with LTG participated in the humoral and cellular immunological study. Of these, 2 patients developed a rash during LTG treatment and are described in detail. Results: No modifications of humoral or cellular immunity (measured at 1 and 3 months) were noted in 14 of the 16 patients during this treatment. In the 2 children who manifested rash, basal immune function was normal. In both, immediately after the skin rash appeared, there was a high increase in the percentage of activated T-helper lymphocytes (CD4-DR) and activated T-suppressor lymphocytes (CD8-DR), a slight increase in percentage of B lymphocytes (CD19), and a greater increase in serum concentration of IgE. In 1 of the 2 patients, reevaluation of immunity 20 days after the rash appeared and after LTG suspension showed normal percentages of CD4-DR, CD8-DR, and CD19, whereas the serum concentration of IgE had decreased. Conclusions: The observed immunological results indicate that LTG-induced rash may be considered an immune-mediated hypersensitivity reaction.

Original languageEnglish
Pages (from-to)502-507
Number of pages6
Issue number5
Publication statusPublished - 1998


  • Hypersensitivity
  • Immune system
  • Lamotrigine
  • Rash

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)


Dive into the research topics of 'Lamotrigine hypersensitivity in childhood epilepsy'. Together they form a unique fingerprint.

Cite this